Notícias Lisata Therapeutics Inc - LSTA | Ações NASDAQ | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

As Melhores Corretoras Online

Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Lisata Therapeutics Inc (LSTA)
Lisata Therapeutics Inc (LSTA) Notícias

Lisata Therapeutics Inc (LSTA)

2,38

0,0995

(4,36%)

Fechado 24 Março 5:00PM

Atrasado por 15 minutos

2,35

-0,03

(-1,26%)

Após o horário de negociação: 8:59PM

Atrasado por 15 minutos

Discussões em tempo real e ideias de negociação: Negocie com confiança com nossa poderosa plataforma.

Lisata Therapeutics to Present at the Investival Showcase USA

Lisata Therapeutics and GATC Health Consummate First Step in Strategic Collaboration to use AI to Derisk and Accelerate Drug Development

Lisata Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update

Lisata Therapeutics to Report Full Year 2024 Financial Results and Provide a Business Update on Thursday, February 27, 2025

Lisata Therapeutics to Present at the 2025 BIO CEO & Investor Conference

Lisata Therapeutics and WARPNINE Announce Encouraging Preliminary Results from the Phase 1b/2a iLSTA Trial Evaluating Certepetide in Locally Advanced Non-Resectable Pancreatic Ductal Adenocarcinoma

Lisata Therapeutics Reports Encouraging Preliminary Cohort A Data from the AGITG-led Phase 2 ASCEND Trial Evaluating Certepetide with Standard-of-Care Chemotherapy in Metastatic Pancreatic Ductal Adenocarcinoma

Lisata Therapeutics to Present at the 2025 Sequire Investor Summit

Lisata Therapeutics Announces Completion of Enrollment in the CENDIFOX Trial

Lisata Therapeutics and Kuva Labs Announce Global License Agreement for Solid Tumor Imaging

Lisata Therapeutics Wins 2024 BioTech Breakthrough Award for ‘Specialized BioTherapeutics Company of the Year’

Lisata Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

Lisata Therapeutics and Valo Therapeutics Announce Preclinical Research Collaboration

Lisata Therapeutics to Report Third Quarter 2024 Financial Results and Provide a Business Update on Tuesday, November 12, 2024

Lisata Therapeutics to Participate in Upcoming November 2024 Industry and Investor Events

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

Lisata Therapeutics

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições